Bailard’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-261
| Closed | -$226K | – | 721 |
|
|
2021
Q1 | $226K | Sell |
261
-244
| -48% | -$211K | 0.01% | 622 |
|
|
2020
Q4 | $468K | Sell |
505
-141
| -22% | -$131K | 0.02% | 344 |
|
|
2020
Q3 | $664K | Buy |
646
+120
| +23% | +$123K | 0.03% | 251 |
|
|
2020
Q2 | $533K | Hold |
526
| – | – | 0.03% | 263 |
|
|
2020
Q1 | $457K | Buy |
526
+120
| +30% | +$104K | 0.03% | 240 |
|
|
2019
Q4 | $435K | Buy |
406
+46
| +13% | +$49.3K | 0.02% | 318 |
|
|
2019
Q3 | $333K | Sell |
360
-200
| -36% | -$185K | 0.02% | 379 |
|
|
2019
Q2 | $633K | Buy |
560
+240
| +75% | +$271K | 0.04% | 252 |
|
|
2019
Q1 | $435K | Hold |
320
| – | – | 0.03% | 329 |
|
|
2018
Q4 | $370K | Hold |
320
| – | – | 0.03% | 373 |
|
|
2018
Q3 | $486K | Hold |
320
| – | – | 0.03% | 382 |
|
|
2018
Q2 | $501K | Sell |
320
-80
| -20% | -$125K | 0.03% | 359 |
|
|
2018
Q1 | $462K | Sell |
400
-80
| -17% | -$92.4K | 0.03% | 334 |
|
|
2017
Q4 | $569K | Buy |
+480
| New | +$569K | 0.04% | 299 |
|